Better Therapeutics data on apps’ benefit with GLP-1s, Orexo hits a snag

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.

Diabetes: Better shows data on app’s benefit with GLP-1s

Better Therapeutics announced top-line data suggesting that its prescription app for diabetes treatment, AspyreRx, can boost the impact of GLP-1 diabetes treatments. According to the release, a subgroup analysis of 160 participants in its pivotal trial on GLP-1 treatment found that the behavior modification app produced statistically significant reductions in A1C compared to a control group.

Get unlimited access to award-winning journalism and exclusive events.

Over 80% of Nurses Face Workplace Violence, Survey Finds

U.S. nurses reported a surge in workplace violence in post-pandemic times, according to a new survey from the nation’s largest nursing union. In National Nurses

February 6, 2024

Smooth and glowing skin starts with these top face scrubs – The Cannabist

Which face scrub is best? If you want radiant, smooth skin with a healthy, youthful glow, add a facial scrub to your skin care routine.

September 13, 2024

Heat-Related Texas Deaths Climb After Beryl Left Millions Without Power

SPRING, Texas — As the temperature soared in the Houston-area home Janet Jarrett shared with her sister after losing electricity in Hurricane Beryl, she did

July 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.